SouthRampartPharma

SRP's CEO & Co-Founder, @HernanBazanMD, participated in a @IAmBiotech panel focused on the challenges in the development of new drugs in the #pain and #addiction space. The panel, which included @DavidThomasCFA, is analyzed in the following article. #NSAID bio.news/bio-convention…

SRP's CEO & Co-Founder @HernanBazanMD is featured in the latest episode of @IAmBiotech to discuss the ‘all hands on deck’ approach needed to advance #pain #innovation with other experts in the field. #NSAID #acetaminophen #opioids Listen here: bio.org/podcast

Our CFO, Josh Blacher, MBA was interviewed as part of a digital roundtable for @PharmExec. The discussion centered around the latest economic changes in the #lifesciences field. #chronicpain #acute #acetaminophen #CFO Read here: pharmexec.com/view/focus-and…

#ICYMI - South Rampart CEO & Co-Founder @HernanBazanMD joined @Founders_pod to discuss the advancements in #painmanagement, and how to face direct business challenges. #pain #acetaminophen #acutepain #NSAID #paintherapy Make sure to give it a listen: anchor.fm/founderskeepers

For her latest @BioSpace article focused on the challenges in the pain therapeutics field, @lisagmunger interviews South Rampart Pharma’s CEO & Co-Founder, @HernanBazanMD, following his @BIOConvention panel. #pain #NSAID #chronic Read the article: biospace.com/article/panel-…

Our Co-Founder & CEO, @HernanBazanMD, and CFO Josh Blacher, MBA, had productive investor meetings, made new connections, and presented company updates at @IAmBiotech CEO & Investor Conference in New York, NY. #pain #opioids #acetominaphen #chronic #NSAID

👏Our CEO, @HernanBazanMD, participated today at the @IAmBiotech CEO & Investor Conference in a panel on #pain and #addiction therapeutics #innovation with a VP from #BIO and Program Directors from #NIH and the U.S. Pain Foundation. Learn more by visiting our website!

Tune in on Tuesday, February 7, as our Co-Founder & CEO @HernanBazanMD speaks at a panel during the @IAmBiotech BIO CEO & Investor Conference. #pain #opioids #acetominaphen #NSAID #chronic #acute Add it to your calendar: bio.org/events/bio-ceo…

We are thrilled to announce our participation at the 2023 @IAmBiotech BIO CEO & Investor Conference. Our CEO & Co-Founder, @HernanBazanMD, and CFO Josh Blacher, MBA, will be available for one-on-one meetings with investors. #pain #opioids Read the release: prnewswire.com/news-releases/…

South Rampart Co-Founder & CEO @HernanBazanMD has been selected for an in-person Company Presentation at the @IAmBiotech BIO CEO & Investor Conference in New York, NY. For virtual attendance, register at: bio.org/events/bio-ceo… #pain #opioids #acetominaphen #chronic

The South Rampart Pharma team, with @HernanBazanMD and Josh Blacher, had an incredible time in San Francisco for #JPM2023. It was great being able to meet with everyone there and develop significant connections. Until next year! #pain #opioids #NSAID #acetaminophen

On Monday, January 23, our CEO & Co-Founder @HernanBazanMD wrote an article on the #opioidcrisis, its devastating effects, and possible solutions. Check out the article via @dcexaminer here: washingtonexaminer.com/restoring-amer…

Our CEO & Co-Founder, @HernanBazanMD, was featured in @ScripEleanor‘s “Scrip Asks...What Does 2023 Hold For Biopharma?” where he discussed the effects of hybrid approaches on the Biotech world. #opioids #acetominaphen #NSAID #chronic #acute Read: scrip.pharmaintelligence.informa.com/SC147621/Scrip…

On Jan. 9 at #BioTechShowcase South Rampart Pharma CEO & Co-Founder @HernanBazanMD presented our novel non-opioid clinical lead asset as part of #JPM2023. #innovation #chronicpain #acutepain #neuropathy

Check out a recent article @LifeSciLeader1 featuring our CEO, @HernanBazanMD, discussing the company’s journey towards developing effective #nonaddictive #pain medicines. Read >> lifescienceleader.com/doc/a-new-fund… #opioids #NSAID #acetaminophen #opioidcrisis #biotech #pharma #Innovation

We will be presenting our novel non-opioid clinical lead asset at #BiotechShowcase during #JPM2023 on Jan. 9 at 10:15 am PT in Franciscan C. Learn about the clinical development of SRP-001, our novel, non-opioid, non-addictive innovation for chronic and acute #pain management.

Our CEO & Co-Founder, @HernanBazanMD, discusses the unmet need for safer #pain management in a @MedCityNews article titled, “Current Lack of Innovation in the Pain Space Hurts Society.” Read: medcitynews.com/2022/12/curren… #opioids #acetominaphen #NSAID #chronic #acute

Our CEO & Co-Founder @HernanBazanMD discusses creative fundraising and strategics with @WSJ’s Brian Gormley and executives from Axcelius, @canaanpartners, @Triumvirainc, @MassiveBio, and SFA Therapeutics. Read: on.wsj.com/3WlcTpr #opioids #acetominaphen #NSAID #pain.

Our CEO and Co-founder, Dr. Hernan Bazan, discusses with John Parkinson of @medicalwrldnews the complications with #opioid, #acetominaphen use, and #NSAID use, and emphasizes the need for innovations in the safer treatment of chronic & acute #pain. Watch bit.ly/3Htrtqa

Thanks to @NOLAnews for highlighting the wide-ranging scientific contributions of our co-founder, Dr. Nicolas Bazan, and making the case for the value of investing in important research. Read more below: nola.com/opinions/our_v…